A Study of AUR104 in Patients With Relapsed/Refractory Lymphoid Malignancies (VIJAY-1)
Clinical trial NCT06761586 · TERMINATED
Trial details
- NCT number
- NCT06761586
- Sponsor
- Aurigene Discovery Technologies Limited
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-12
- Primary completion
- 2026-02-10
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.